WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/028045    International Application No.:    PCT/US1999/027009
Publication Date: 18.05.2000 International Filing Date: 12.11.1999
Chapter 2 Demand Filed:    06.06.2000    
A61K 38/00 (2006.01), C12N 9/14 (2006.01)
Applicants: INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive Palo Alto, CA 94304 (US) (For All Designated States Except US).
TANG, Tom, Y. [CN/US]; (US) (For US Only).
HILLMAN, Jennifer, L. [US/US]; (US) (For US Only).
YUE, Henry [US/US]; (US) (For US Only).
LAL, Preeti [IN/US]; (US) (For US Only).
BANDMAN, Olga [US/US]; (US) (For US Only).
CORLEY, Neil, C. [US/US]; (US) (For US Only).
GUEGLER, Karl, J. [CH/US]; (US) (For US Only).
BAUGHN, Mariah, R. [US/US]; (US) (For US Only).
LU, Dyung, Aina, M. [US/US]; (US) (For US Only).
AZIMZAI, Yalda [US/US]; (US) (For US Only).
YANG, Junming [CN/US]; (US) (For US Only)
Inventors: TANG, Tom, Y.; (US).
HILLMAN, Jennifer, L.; (US).
YUE, Henry; (US).
LAL, Preeti; (US).
BANDMAN, Olga; (US).
CORLEY, Neil, C.; (US).
GUEGLER, Karl, J.; (US).
BAUGHN, Mariah, R.; (US).
LU, Dyung, Aina, M.; (US).
AZIMZAI, Yalda; (US).
YANG, Junming; (US)
Agent: PASQUALONE, Danielle; Legal Department Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304 (US)
Priority Data:
60/172,256 12.11.1998 US
60/135,519 21.05.1999 US
09/190,937 12.11.1998 US (Priority Withdrawn 21.03.2000)
Abstract: front page image
(EN)The invention provides human hydrolase proteins (HYDRL) and polynucleotides which identify and encode HYDRL. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HYDRL.
(FR)L'invention concerne des hydrolases humaines (HYDRL), ainsi que des polynucléotides identifiant et codant pour HYDRL. Elle se rapporte également à des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes, et propose des méthodes de diagnostique, de traitement ou de prévention de troubles associés à l'expression de HYDRL.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)